CN102784216B - 一种治疗脱发的藏药 - Google Patents
一种治疗脱发的藏药 Download PDFInfo
- Publication number
- CN102784216B CN102784216B CN 201210333890 CN201210333890A CN102784216B CN 102784216 B CN102784216 B CN 102784216B CN 201210333890 CN201210333890 CN 201210333890 CN 201210333890 A CN201210333890 A CN 201210333890A CN 102784216 B CN102784216 B CN 102784216B
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- hair
- alopecia
- group
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 50
- 231100000360 alopecia Toxicity 0.000 title claims abstract description 40
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 229940040145 liniment Drugs 0.000 claims description 4
- 239000000865 liniment Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 229940098465 tincture Drugs 0.000 claims description 4
- -1 extractum Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 210000004209 hair Anatomy 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004761 scalp Anatomy 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 206010040844 Skin exfoliation Diseases 0.000 abstract description 4
- 230000035618 desquamation Effects 0.000 abstract description 4
- 230000003676 hair loss Effects 0.000 abstract description 3
- 201000009495 Hypotrichosis Diseases 0.000 abstract description 2
- 206010039792 Seborrhoea Diseases 0.000 abstract description 2
- 241000001522 Terminalia chebula Species 0.000 abstract description 2
- 235000011517 Terminalia chebula Nutrition 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract description 2
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000220304 Prunus dulcis Species 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000013641 positive control Substances 0.000 description 21
- 230000004089 microcirculation Effects 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 210000003780 hair follicle Anatomy 0.000 description 8
- 230000003779 hair growth Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 206010068168 androgenetic alopecia Diseases 0.000 description 7
- 201000002996 androgenic alopecia Diseases 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 238000012856 packing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000036770 blood supply Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010049865 Achromotrichia acquired Diseases 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229910052621 halloysite Inorganic materials 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003752 improving hair Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000407877 Combretum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000058281 Ulmus pumila Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000024349 endocrine alopecia Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008336 microcirculatory blood flow Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 150000004760 silicates Chemical group 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210333890 CN102784216B (zh) | 2012-09-11 | 2012-09-11 | 一种治疗脱发的藏药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210333890 CN102784216B (zh) | 2012-09-11 | 2012-09-11 | 一种治疗脱发的藏药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102784216A CN102784216A (zh) | 2012-11-21 |
CN102784216B true CN102784216B (zh) | 2013-09-11 |
Family
ID=47149935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210333890 Active CN102784216B (zh) | 2012-09-11 | 2012-09-11 | 一种治疗脱发的藏药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102784216B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114903925A (zh) * | 2021-02-10 | 2022-08-16 | 伽蓝(集团)股份有限公司 | 一种诃子果提取物的应用及含其的生发育发产品 |
CN115414424B (zh) * | 2022-04-15 | 2024-03-22 | 西藏自治区藏医院(西藏自治区藏医药研究院) | 一种防治脱发可育发的余甘子喷剂及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1485024A (zh) * | 2002-09-28 | 2004-03-31 | 戚海波 | 一种蜂蜜及在美容化妆品中的应用 |
CN102014940A (zh) * | 2008-05-02 | 2011-04-13 | 株式会社太平洋 | 草药加工而成的药用植物提取物和含有该提取物的皮肤外用组合物 |
-
2012
- 2012-09-11 CN CN 201210333890 patent/CN102784216B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1485024A (zh) * | 2002-09-28 | 2004-03-31 | 戚海波 | 一种蜂蜜及在美容化妆品中的应用 |
CN102014940A (zh) * | 2008-05-02 | 2011-04-13 | 株式会社太平洋 | 草药加工而成的药用植物提取物和含有该提取物的皮肤外用组合物 |
Non-Patent Citations (6)
Title |
---|
杨明非.榆树皮粗多糖组成及体外抗氧化作用.《东北林业大学学报》.2011,第39卷(第09期), |
榆树皮粗多糖组成及体外抗氧化作用;杨明非;《东北林业大学学报》;20110930;第39卷(第09期);第125页第1栏倒数第1段-第2栏倒数1-2段 * |
罗达尚.藏药资源及其研究、开发.《中国藏学》.1997,(第04期), |
藏药资源及其研究、开发;罗达尚;《中国藏学》;19970430(第04期);49-58 * |
雄激素源性脱发的中医药治疗进展;魏跃钢等;《黑龙江中医药》;20110430(第04期);第63页第1栏第3段-第2栏第2段 * |
魏跃钢等.雄激素源性脱发的中医药治疗进展.《黑龙江中医药》.2011,(第04期), |
Also Published As
Publication number | Publication date |
---|---|
CN102784216A (zh) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN103041184B (zh) | 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 | |
CN101979041A (zh) | 一种治疗多种皮肤病的中药制剂 | |
CN108743729A (zh) | 一种治疗脂溢性脱发的草本组合物及纳米育发液 | |
CN101647857B (zh) | 治疗多囊卵巢综合征的中药组合物及其制备方法 | |
CN101011483B (zh) | 治疗小儿消化系统疾病的中药制剂及其制备方法 | |
CN102784216B (zh) | 一种治疗脱发的藏药 | |
CN105055849A (zh) | 滋阴养肾的中药提取物及其制备方法和应用 | |
CN103405620A (zh) | 一种治疗脂溢性脱发及斑秃的中药制剂及其制备方法 | |
CN106421590A (zh) | 一种用于治疗色斑的药物制剂及其用途 | |
CN110368445A (zh) | 一种治疗银屑病的中药组合物及其制备方法和应用 | |
CN103638199B (zh) | 一种防治神经衰弱和老年痴呆的中药组合物及其制备方法 | |
CN105213807A (zh) | 用于治疗阴虚火旺型复发性口腔溃疡的药物 | |
CN105031032A (zh) | 一种用于治疗脱发的中药组合物、中药口服剂及其制备方法 | |
CN102793771B (zh) | 一种治疗脱发藏药的制备方法 | |
CN102652808B (zh) | 一种调经养容胶囊 | |
CN102048913B (zh) | 一种治疗更年期综合症的中药制剂及其制备方法 | |
CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
CN100409885C (zh) | 一种治疗外阴硬化性苔癣的药物 | |
CN108403869B (zh) | 一种用于祛黄褐斑的中药组合物及其制备方法 | |
CN104274584B (zh) | 一种治疗脱发藏药的制备方法 | |
CN106822300B (zh) | 一种祛痘美颜的中药制剂 | |
CN104274585B (zh) | 一种治疗脱发藏药的制备方法 | |
CN103041194A (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN103432333B (zh) | 一种治疗甲状腺机能减退症的中药有效部位组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Tibetan medicine for treating alopecia Effective date of registration: 20200525 Granted publication date: 20130911 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2020630000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210517 Granted publication date: 20130911 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2020630000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Tibetan medicine for hair loss Effective date of registration: 20210602 Granted publication date: 20130911 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo Registration number: Y2021630000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230608 Granted publication date: 20130911 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo|Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230821 Address after: Room 1231, Building 11, No. 90 Wusi West Road, Chengxi District, Xining City, Qinghai Province, 810000 Patentee after: Yang Cuoji Address before: 810003 No.18 Jingsan Road, Biotechnology Industrial Park, Xining City, Qinghai Province Patentee before: Jiumei Pengcuo |